You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ICATIBANT ACETATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Icatibant Acetate, and what generic alternatives are available?

Icatibant Acetate is a drug marketed by Alembic, Cipla, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Glenmark Pharms Ltd, Jiangsu Hansoh Pharm, Nang Kuang Pharm Co, Teva Pharms Usa, and Wilshire Pharms Inc. and is included in ten NDAs.

The generic ingredient in ICATIBANT ACETATE is icatibant acetate. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the icatibant acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Icatibant Acetate

A generic version of ICATIBANT ACETATE was approved as icatibant acetate by TEVA PHARMS USA on July 15th, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ICATIBANT ACETATE?
  • What are the global sales for ICATIBANT ACETATE?
  • What is Average Wholesale Price for ICATIBANT ACETATE?
Summary for ICATIBANT ACETATE
Drug patent expirations by year for ICATIBANT ACETATE
Pharmacology for ICATIBANT ACETATE
Paragraph IV (Patent) Challenges for ICATIBANT ACETATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FIRAZYR Injection icatibant acetate 10 mg/mL 022150 2 2015-08-25

US Patents and Regulatory Information for ICATIBANT ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic ICATIBANT ACETATE icatibant acetate INJECTABLE;SUBCUTANEOUS 213773-001 Jun 14, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Jiangsu Hansoh Pharm ICATIBANT ACETATE icatibant acetate INJECTABLE;SUBCUTANEOUS 211021-001 Mar 9, 2020 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma ICATIBANT ACETATE icatibant acetate INJECTABLE;SUBCUTANEOUS 213521-001 Aug 14, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.